563
Views
12
CrossRef citations to date
0
Altmetric
Review

Developing therapeutic strategies to promote myelin repair in multiple sclerosis

ORCID Icon, , , , , , & show all
Pages 997-1013 | Received 22 Mar 2019, Accepted 12 Jun 2019, Published online: 20 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pablo Villoslada & Lawrence Steinman. (2020) New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opinion on Investigational Drugs 29:5, pages 443-459.
Read now
Lukmanee Tradtrantip, Nithi Asavapanumas & Alan S. Verkman. (2020) Emerging therapeutic targets for neuromyelitis optica spectrum disorder. Expert Opinion on Therapeutic Targets 24:3, pages 219-229.
Read now
Karl J. M. Hanf, Joseph W. Arndt, YuTing Liu, Bang Jian Gong, Mia Rushe, Richelle Sopko, Ramiro Massol, Benjamin Smith, Yan Gao, Isin Dalkilic-Liddle, Xinhua Lee, Shanell Mojta, Zhaohui Shao, Sha Mi & R. Blake Pepinsky. (2020) Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site. mAbs 12:1.
Read now

Articles from other publishers (9)

Hongshun Sun, Yijing Du, Xu Chen, Hong Jiang, Yulong Li & Linjiang Shen. (2023) Design, synthesis, and evaluation of nile red analogs for myelin imaging as near-infrared fluorescence probe. Dyes and Pigments 208, pages 110804.
Crossref
Feng-Yi Yang, Li-Hsin Huang, Meng-Ting Wu & Zih-Yun Pan. (2022) Ultrasound Neuromodulation Reduces Demyelination in a Rat Model of Multiple Sclerosis. International Journal of Molecular Sciences 23:17, pages 10034.
Crossref
Hesham Abboud, Andrea Salazar-Camelo, Naveen George, Sarah M. Planchon, Marcelo Matiello, Maureen A. Mealy, Andrew Goodman, Raed Alroughani, Ayse Altintas, Metha Apiwattanakul, Nasrin Asgari, Renata Barbosa Paolilo, Jeffrey Bennett, Denis Bernardi Bichuetti, Terrence F. Blaschke, Alexey Boyko, Simon Broadley, Edgar Carnero Contentti, Jeffrey A. Cohen, Guillermo Delgado-Garcia, Irena Dujmovic Basuroski, Jose Flores-Rivera, Kazuo Fujihara, Joachim Havla, Kerstin Hellwig, Jyh Yung Hor, Saif Huda, Raffaele Iorio, Sven Jarius, Dorlan Kimbrough, Ilya Kister, Ingo Kleiter, Najib Kissani, Marco Lana-Peixoto, Maria Isabel Leite, Michael Levy, Youssoufa Maiga, Yang Mao-Draayer, Sara Mariotto, Esther Melamed, Veronika E. Neubrand, Celia Oreja-Guevara, Jacqueline Palace, Anne-Katrin Pröbstel, Peiqing Qian, Chao Quan, Claire Riley, Marius Ringelstein, Maria Jose Sa, Sasitorn Siritho, Terry J. Smith, Ibis Soto de Castillo, Silvia Tenembaum, Pablo Villoslada, Jens Wuerfel, Dean Wingerchuk, Bassem Yamout & Michael Yeaman. (2021) Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders. Journal of Neurology 269:4, pages 1786-1801.
Crossref
Alexandr KlistornerMichael Barnett. (2021) Remyelination Trials. Neurology Neuroimmunology & Neuroinflammation 8:6.
Crossref
Annarita Del Gatto, Michele Saviano & Laura Zaccaro. (2021) An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis. Molecules 26:17, pages 5227.
Crossref
Jialin He, Yan Huang, Jianyang Liu, Ziwei Lan, Xiangqi Tang & Zhiping Hu. (2021) The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis. Frontiers in Immunology 12.
Crossref
Marta Waliszewska-Prosół, Justyna Chojdak-Łukasiewicz, Sławomir Budrewicz & Anna Pokryszko-Dragan. (2021) Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects. International Journal of Molecular Sciences 22:6, pages 2801.
Crossref
Thomas O. Schrader, Yifeng Xiong, Ariana O. Lorenzana, Alexander Broadhead, Karin J. Stebbins, Michael M. Poon, Christopher Baccei & Daniel S. Lorrain. (2020) Discovery of PIPE-359, a Brain-Penetrant, Selective M 1 Receptor Antagonist with Robust Efficacy in Murine MOG-EAE . ACS Medicinal Chemistry Letters 12:1, pages 155-161.
Crossref
Gabrielle Macaron & Daniel Ontaneda. (2019) Diagnosis and Management of Progressive Multiple Sclerosis. Biomedicines 7:3, pages 56.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.